This is a Validated Antibody Database (VAD) review about mouse Cd28, based on 149 published articles (read how Labome selects the articles), using Cd28 antibody in all methods. It is aimed to help Labome visitors find the most suited Cd28 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Invitrogen
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...
Invitrogen Cd28 antibody (Invitrogen, 37.51) was used in blocking or activating experiments on mouse samples . Arthritis Res Ther (2021) ncbi
Syrian golden hamster monoclonal (37.51)
  • flow cytometry; mouse
Invitrogen Cd28 antibody (eBioscience, 37.51) was used in flow cytometry on mouse samples . Mucosal Immunol (2021) ncbi
Syrian golden hamster monoclonal (37.51)
  • flow cytometry; human; fig 2e
Invitrogen Cd28 antibody (eBioscience, 37.51) was used in flow cytometry on human samples (fig 2e). Cell (2020) ncbi
Syrian golden hamster monoclonal (37.51)
  • flow cytometry; mouse; loading ...; fig 1d
Invitrogen Cd28 antibody (eBiosciences, 37.51) was used in flow cytometry on mouse samples (fig 1d). J Exp Med (2019) ncbi
Syrian golden hamster monoclonal (37.51)
  • flow cytometry; human; loading ...; fig 6a
Invitrogen Cd28 antibody (eBioscience, 37.51) was used in flow cytometry on human samples (fig 6a). Front Immunol (2018) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...; fig s5b
Invitrogen Cd28 antibody (Thermo Fisher Scientific, 16-0281-82) was used in blocking or activating experiments on mouse samples (fig s5b). Immunity (2018) ncbi
Syrian golden hamster monoclonal (37.51)
  • flow cytometry; mouse; fig 2a
Invitrogen Cd28 antibody (eBioscience, 12-0281-82) was used in flow cytometry on mouse samples (fig 2a). Immunity (2017) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...; fig s2d
In order to investigate how aging affects transcriptional dynamics in naive and CD4 positive T cells, Invitrogen Cd28 antibody (eBiosciences, 16-0281-82) was used in blocking or activating experiments on mouse samples (fig s2d). Science (2017) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...; fig 3
In order to study the D. farinae allergen Pplase in a mouse model., Invitrogen Cd28 antibody (Ebioscience, 16-0281-82) was used in blocking or activating experiments on mouse samples (fig 3). Sci Rep (2017) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...; fig 7
In order to explore if the binding strength of a peptide for a MHC is a critical factor to determine the duration of pMHC-mediated T cell activation, Invitrogen Cd28 antibody (eBioscience, 37.51) was used in blocking or activating experiments on mouse samples (fig 7). Mol Cells (2017) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; fig 5
In order to asked if deleting FURIN from immune cells would strengthen anticancer responses, Invitrogen Cd28 antibody (eBioscience, 37.51) was used in blocking or activating experiments on mouse samples (fig 5). Oncoimmunology (2016) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...; fig 2f
In order to analyze the in vivo effect of atorvastatin on regulatory T cells and its association with the inflammatory process in a model of allergic asthma, Invitrogen Cd28 antibody (eBioscience, 37.51) was used in blocking or activating experiments on mouse samples (fig 2f). Front Immunol (2016) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; 2 ug/ml; loading ...
In order to assess if aerobic glycolysis and glutaminolysis co-operatively reduce UDP-GlcNAc biosynthesis and N-glycan branching in mouse T cell blasts, Invitrogen Cd28 antibody (eBioscience, 37.51) was used in blocking or activating experiments on mouse samples at 2 ug/ml. elife (2017) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...; fig s3e
In order to discuss how NLRC3 protects against colorectal cancer by modulating mTor signaling, Invitrogen Cd28 antibody (Affymetrix eBioscience, 16-0281) was used in blocking or activating experiments on mouse samples (fig s3e). Nature (2016) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...; fig 9a
In order to identify and characterize a Nei endonuclease VIII-like 3 mutation in three siblings from a consanguineous family with autoimmunity, Invitrogen Cd28 antibody (eBioscience, 37.51) was used in blocking or activating experiments on mouse samples (fig 9a). J Clin Invest (2016) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; 1 ug/ml; fig s6c
In order to investigate allergic responses to food allergens in WASP-deficient animals, Invitrogen Cd28 antibody (BD Pharmingen, 16-0281-85) was used in blocking or activating experiments on mouse samples at 1 ug/ml (fig s6c). J Clin Invest (2016) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...; fig 1e
In order to investigate the effects of modulating potassium ion concentration on T cell effector functions, Invitrogen Cd28 antibody (eBioscience, 37-51) was used in blocking or activating experiments on mouse samples (fig 1e). Nature (2016) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; 8 ug/ml; loading ...; fig s5c
In order to test if modulation of Rho-associated kinase 2 alters the generation of T follicular helper cells, Invitrogen Cd28 antibody (eBioscience, 16-0281-85) was used in blocking or activating experiments on mouse samples at 8 ug/ml (fig s5c). Sci Signal (2016) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; fig 3h
Invitrogen Cd28 antibody (eBiosience, 16-0281-86) was used in blocking or activating experiments on mouse samples (fig 3h). Nat Commun (2016) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...; fig 5g
In order to discuss Staphylococcus aureus-derived allergens, Invitrogen Cd28 antibody (eBioscience, 14-0281-81) was used in blocking or activating experiments on mouse samples (fig 5g). J Allergy Clin Immunol (2017) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; 3 ug/ml; fig 2
Invitrogen Cd28 antibody (eBioscience, 37.51) was used in blocking or activating experiments on mouse samples at 3 ug/ml (fig 2). Nat Immunol (2016) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...; fig s2c
In order to elucidate the relationship between Wnt/beta-catenin and Hippo/YAP signaling during intestinal regeneration and tumorigenesis, Invitrogen Cd28 antibody (eBiosciences, 37.51) was used in blocking or activating experiments on mouse samples (fig s2c). Dev Cell (2016) ncbi
Syrian golden hamster monoclonal (37.51)
  • flow cytometry; mouse; 1:1000; loading ...; fig 2c
In order to investigate the role of IL-1beta produced by a T helper 17 cell-intrinsic ASC-NLRP3-caspase-8 inflammasome in experimental autoimmune encephalomyelitis, Invitrogen Cd28 antibody (eBioscience, 37.51) was used in flow cytometry on mouse samples at 1:1000 (fig 2c). Nat Immunol (2016) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; fig 4
In order to establish that autophagy is essential for maintenance of a balanced CD4 positive intestinal T cell response, Invitrogen Cd28 antibody (eBioscience, 37.51) was used in blocking or activating experiments on mouse samples (fig 4). elife (2016) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; fig 4
Invitrogen Cd28 antibody (eBioscience, 37.51) was used in blocking or activating experiments on mouse samples (fig 4). J Exp Med (2016) ncbi
Syrian golden hamster monoclonal (37.51)
  • flow cytometry; mouse; fig s9
Invitrogen Cd28 antibody (eBioscience, 14-02281-86) was used in flow cytometry on mouse samples (fig s9). Sci Rep (2016) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...; fig 4a
In order to elucidate the role of TfR1 in adaptive immunity, Invitrogen Cd28 antibody (eBioscience, 37.51) was used in blocking or activating experiments on mouse samples (fig 4a). Nat Genet (2016) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; fig 4a
In order to study the interactions between hepatoma cells and anti-hepatocellular carcinoma T-cells, Invitrogen Cd28 antibody (eBiosciences, 37.51) was used in blocking or activating experiments on mouse samples (fig 4a). Immunol Cell Biol (2016) ncbi
Syrian golden hamster monoclonal (37.51)
  • flow cytometry; mouse; fig 2
Invitrogen Cd28 antibody (eBioscience, 37.51) was used in flow cytometry on mouse samples (fig 2). J Virol (2016) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; fig 1f
  • flow cytometry; mouse; 1 ug/ml; fig 1b
Invitrogen Cd28 antibody (eBioscience, 37.51) was used in blocking or activating experiments on mouse samples (fig 1f) and in flow cytometry on mouse samples at 1 ug/ml (fig 1b). Nat Immunol (2015) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; 1:500
In order to study PI3Kdelta in CD8+ T cells during infection with Listeria monocytogenes, Invitrogen Cd28 antibody (eBioscience, 37.51) was used in blocking or activating experiments on mouse samples at 1:500. J Immunol (2015) ncbi
Syrian golden hamster monoclonal (37.51)
  • flow cytometry; mouse; tbl s1
In order to study the role of ICOS in group 2 innate lymphoid cell responses, Invitrogen Cd28 antibody (eBiosciences, 37.51) was used in flow cytometry on mouse samples (tbl s1). Biochem Biophys Res Commun (2015) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse
Invitrogen Cd28 antibody (eBioscience, 37.51) was used in blocking or activating experiments on mouse samples . J Immunol (2015) ncbi
Syrian golden hamster monoclonal (37.51)
  • flow cytometry; mouse; fig 1
In order to elucidate the mechanisms by which RANKL promotes bone formation and erosion, Invitrogen Cd28 antibody (eBioscience, 37.51) was used in flow cytometry on mouse samples (fig 1). J Bone Miner Res (2015) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...; fig 2
In order to assess the role of glycogen synthase kinase-3 in the production of IL-10 by CD4 positive T helper cells, Invitrogen Cd28 antibody (eBioscience, 37.51) was used in blocking or activating experiments on mouse samples (fig 2). Eur J Immunol (2015) ncbi
Syrian golden hamster monoclonal (37.51)
  • flow cytometry; mouse; fig 3a
In order to investigate the effect of IL-7 and anti-PD-1 treatment in sepsis model followed by Candida albicans infection, Invitrogen Cd28 antibody (eBioscience, 12-0281-81) was used in flow cytometry on mouse samples (fig 3a). Shock (2015) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; 2 ug/ml
In order to identify Cd8 cis-regulatory elements, Invitrogen Cd28 antibody (eBioscience, 37.51) was used in blocking or activating experiments on mouse samples at 2 ug/ml. J Leukoc Biol (2015) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; 5 ug/ml
  • flow cytometry; mouse; 5 ug/ml
Invitrogen Cd28 antibody (eBioscience, 37.51) was used in blocking or activating experiments on mouse samples at 5 ug/ml and in flow cytometry on mouse samples at 5 ug/ml. J Leukoc Biol (2015) ncbi
Syrian golden hamster monoclonal (37.51)
  • flow cytometry; mouse
Invitrogen Cd28 antibody (eBioscience, 37.51) was used in flow cytometry on mouse samples . EMBO J (2014) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; fig 1e
Invitrogen Cd28 antibody (eBioscience, 37.51) was used in blocking or activating experiments on mouse samples (fig 1e). Nat Immunol (2014) ncbi
Syrian golden hamster monoclonal (37.51)
  • flow cytometry; mouse
Invitrogen Cd28 antibody (eBioscience, 37.51) was used in flow cytometry on mouse samples . J Virol (2014) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; fig 1
Invitrogen Cd28 antibody (eBioscience, 16-0281-86) was used in blocking or activating experiments on mouse samples (fig 1). PLoS ONE (2014) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse
In order to investigate the effect of mechanical force on the T cell receptor, Invitrogen Cd28 antibody (eBioscience, 37.51) was used in blocking or activating experiments on mouse samples . Proc Natl Acad Sci U S A (2014) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse
Invitrogen Cd28 antibody (eBioscience, 37.51) was used in blocking or activating experiments on mouse samples . J Immunol (2014) ncbi
Syrian golden hamster monoclonal (37.51)
  • flow cytometry; mouse; 2 ug/ml
Invitrogen Cd28 antibody (eBioscience, 37.51) was used in flow cytometry on mouse samples at 2 ug/ml. Immunology (2014) ncbi
Syrian golden hamster monoclonal (37.51)
  • flow cytometry; mouse; fig 4
Invitrogen Cd28 antibody (eBioscience, 37.51) was used in flow cytometry on mouse samples (fig 4). Scand J Immunol (2014) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; fig 6
Invitrogen Cd28 antibody (eBioscience, 16028185) was used in blocking or activating experiments on mouse samples (fig 6). Autophagy (2013) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; 200 ng/ml
Invitrogen Cd28 antibody (eBioscience, 37.51) was used in blocking or activating experiments on mouse samples at 200 ng/ml. Cell Res (2008) ncbi
Syrian golden hamster monoclonal (37.51)
  • flow cytometry; mouse; fig 1
In order to characterize and compare T helper 1 and 17 cells, Invitrogen Cd28 antibody (eBiosciences, 37.51) was used in flow cytometry on mouse samples (fig 1). J Leukoc Biol (2007) ncbi
Syrian golden hamster monoclonal (37.51)
  • flow cytometry; mouse; 10 ug/ml; fig 2
Invitrogen Cd28 antibody (eBioscience, 37.51) was used in flow cytometry on mouse samples at 10 ug/ml (fig 2). J Immunol (2005) ncbi
BioLegend
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...; fig s2
BioLegend Cd28 antibody (BioLegend, 37.51) was used in blocking or activating experiments on mouse samples (fig s2). J Immunother Cancer (2021) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; 2 ug/ml; loading ...; fig 5b
BioLegend Cd28 antibody (BioLegend, 102102) was used in blocking or activating experiments on mouse samples at 2 ug/ml (fig 5b). Nat Commun (2021) ncbi
Syrian golden hamster monoclonal (37.51)
  • flow cytometry; mouse; 1:200
BioLegend Cd28 antibody (Biolegend, 102114) was used in flow cytometry on mouse samples at 1:200. Commun Biol (2021) ncbi
Syrian golden hamster monoclonal (37.51)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend Cd28 antibody (BioLegend, 37.51) was used in flow cytometry on mouse samples (fig 1a). Aging Cell (2021) ncbi
Syrian golden hamster monoclonal (37.51)
  • flow cytometry; mouse; loading ...; fig 7
BioLegend Cd28 antibody (BioLegend, 102116) was used in flow cytometry on mouse samples (fig 7). elife (2020) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; 1 ug/ml; loading ...; fig 1h
BioLegend Cd28 antibody (BioLegend, 37.51) was used in blocking or activating experiments on mouse samples at 1 ug/ml (fig 1h). Sci Adv (2020) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; 5 ug/ml; loading ...; fig 5d
BioLegend Cd28 antibody (Biolegend, 102116) was used in blocking or activating experiments on mouse samples at 5 ug/ml (fig 5d). Nat Commun (2019) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; 1-10 ug/ml; fig 2a
BioLegend Cd28 antibody (BioLegend, 37.51) was used in blocking or activating experiments on mouse samples at 1-10 ug/ml (fig 2a). Proc Natl Acad Sci U S A (2019) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; 0.5 ug/ml; loading ...; fig 1a
BioLegend Cd28 antibody (BioLegend, 37.51) was used in blocking or activating experiments on mouse samples at 0.5 ug/ml (fig 1a). J Clin Invest (2019) ncbi
Syrian golden hamster monoclonal (37.51)
  • flow cytometry; mouse; fig 1b
BioLegend Cd28 antibody (BioLegend, 37.51) was used in flow cytometry on mouse samples (fig 1b). Sci Rep (2019) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...; fig s8a
BioLegend Cd28 antibody (BioLegend, 102101) was used in blocking or activating experiments on mouse samples (fig s8a). Nat Commun (2018) ncbi
mouse monoclonal (E18)
  • flow cytometry; mouse; loading ...; fig 2g
BioLegend Cd28 antibody (BioLegend, E18) was used in flow cytometry on mouse samples (fig 2g). Circulation (2018) ncbi
mouse monoclonal (E18)
  • flow cytometry; mouse; loading ...; fig s5a
BioLegend Cd28 antibody (Biolegend, E18) was used in flow cytometry on mouse samples (fig s5a). Front Immunol (2018) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...; fig 2a
BioLegend Cd28 antibody (BioLegend, 37.51) was used in blocking or activating experiments on mouse samples (fig 2a). Cell Death Differ (2017) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...; fig 5a
BioLegend Cd28 antibody (BioLegend, 37.51) was used in blocking or activating experiments on mouse samples (fig 5a). J Exp Med (2017) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; 2 ug/ml; loading ...; fig 3b
BioLegend Cd28 antibody (BioLegend, 37.51) was used in blocking or activating experiments on mouse samples at 2 ug/ml (fig 3b). Front Immunol (2017) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; fig 5c
In order to find that TLR3, 7 and 9 deficiencies on host cells result in complete tumor regression and induction of anti-tumor immunity, BioLegend Cd28 antibody (BioLegend, 37.51) was used in blocking or activating experiments on mouse samples (fig 5c). Nat Commun (2017) ncbi
Syrian golden hamster monoclonal (37.51)
  • flow cytometry; mouse; 5 ug/ml; loading ...; fig 4A
In order to find that C-type lectin dendritic cell immunoreceptor is required to modulate lung inflammation and bacterial burden in tuberculosis, BioLegend Cd28 antibody (Biolegend, 37.51) was used in flow cytometry on mouse samples at 5 ug/ml (fig 4A). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (E18)
  • flow cytometry; mouse; loading ...; fig 2b
In order to assess whether human T-cell leukemia virus type 1 bZIP factor enhances the proliferation of expressing T cells after stimulation via the T-cell receptor, BioLegend Cd28 antibody (BioLegend, E18) was used in flow cytometry on mouse samples (fig 2b). PLoS Pathog (2017) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; 5 ug/ml
In order to study the role of T cells in the effector phase of antibody-mediated autoimmune dermatoses, BioLegend Cd28 antibody (Biolegend, 37.51) was used in blocking or activating experiments on mouse samples at 5 ug/ml. Sci Rep (2016) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...; fig 1e
BioLegend Cd28 antibody (BioLegend, 37.51) was used in blocking or activating experiments on mouse samples (fig 1e). Nat Commun (2016) ncbi
Syrian golden hamster monoclonal (37.51)
  • ELISA; mouse; loading ...
In order to suggest that persistent immune activation causes impairment of lymphocytes to respond to chemotactic stimuli, preventing their trafficking from the blood stream to peripheral organs, BioLegend Cd28 antibody (BioLegend, 37.51) was used in ELISA on mouse samples . J Immunol (2017) ncbi
mouse monoclonal (E18)
  • blocking or activating experiments; mouse; loading ...; fig 7a
BioLegend Cd28 antibody (BioLegend, E18) was used in blocking or activating experiments on mouse samples (fig 7a). J Clin Invest (2016) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...; fig 5a
In order to elucidate the mechanisms by which Zfat alters gene expression in T cells, BioLegend Cd28 antibody (Biolegend, 37.51) was used in blocking or activating experiments on mouse samples (fig 5a). Biochim Biophys Acta (2016) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...; fig 2b
In order to elucidate how Batf regulates Th2 immune responses, BioLegend Cd28 antibody (BioLegend, 37.5) was used in blocking or activating experiments on mouse samples (fig 2b). Nat Commun (2016) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; fig s3
BioLegend Cd28 antibody (BioLegend, 37.5) was used in blocking or activating experiments on mouse samples (fig s3). Cancer Immunol Immunother (2016) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; 2 ug/ml; loading ...; fig 2a
In order to investigate how dopamine receptor D3 signaling affects the balance of effector T cells, BioLegend Cd28 antibody (BioLegend, 37.51) was used in blocking or activating experiments on mouse samples at 2 ug/ml (fig 2a). J Immunol (2016) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; fig 3
In order to study the requisite for the function of regulatory T cells known as phosphatase PP2A, BioLegend Cd28 antibody (Biolegend, 37.51) was used in blocking or activating experiments on mouse samples (fig 3). Nat Immunol (2016) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...; fig s6a
BioLegend Cd28 antibody (BioLegend, 37.51) was used in blocking or activating experiments on mouse samples (fig s6a). Gastroenterology (2016) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse
BioLegend Cd28 antibody (BioLegend, 37.51) was used in blocking or activating experiments on mouse samples . Nat Commun (2016) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; 2 ug/ml; fig 4
BioLegend Cd28 antibody (BioLegend, 102102) was used in blocking or activating experiments on mouse samples at 2 ug/ml (fig 4). PLoS ONE (2016) ncbi
mouse monoclonal (E18)
  • flow cytometry; mouse; fig s1
In order to investigate the control of LAT recruitment to the immune synapse and T-cell activation in vivo by IFT20, BioLegend Cd28 antibody (Biolegend, E18) was used in flow cytometry on mouse samples (fig s1). Proc Natl Acad Sci U S A (2016) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; human; fig 1
BioLegend Cd28 antibody (BioLegend, 37.51) was used in blocking or activating experiments on human samples (fig 1). J Immunol (2015) ncbi
Syrian golden hamster monoclonal (37.51)
  • immunoprecipitation; mouse
BioLegend Cd28 antibody (Biolegend, 37.51) was used in immunoprecipitation on mouse samples . Infect Immun (2015) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; 2 ug/ml
In order to report that AMPK regulates protein phosphatase activity to control the of survival and function of CD8+ T cells, thus regulating immune surveillance of tumors, BioLegend Cd28 antibody (Biolegend, 37.51) was used in blocking or activating experiments on mouse samples at 2 ug/ml. Oncotarget (2015) ncbi
mouse monoclonal (E18)
  • flow cytometry; mouse; fig 1
In order to find the primary source of natural IgM, BioLegend Cd28 antibody (BioLegend, E18) was used in flow cytometry on mouse samples (fig 1). J Immunol (2015) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; 20 ug/ml; fig 1
BioLegend Cd28 antibody (BioLegend, 37.51) was used in blocking or activating experiments on mouse samples at 20 ug/ml (fig 1). Sci Signal (2014) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...; fig s2c
In order to study the role of TH9 cells in ulcerative colitis, BioLegend Cd28 antibody (Biolegend, 102102) was used in blocking or activating experiments on mouse samples (fig s2c). Nat Immunol (2014) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; 0.5 ug/ml
BioLegend Cd28 antibody (BioLegend, 37.51) was used in blocking or activating experiments on mouse samples at 0.5 ug/ml. J Clin Invest (2014) ncbi
Bio X Cell
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; 5 ug/ml; loading ...; fig 5s1
Bio X Cell Cd28 antibody (Bio X Cell, BE0015-1) was used in blocking or activating experiments on mouse samples at 5 ug/ml (fig 5s1). elife (2021) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; fig 2e
Bio X Cell Cd28 antibody (BioXcell, 37.51) was used in blocking or activating experiments on mouse samples (fig 2e). elife (2020) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; 1 ug/ml; loading ...; fig 3a
Bio X Cell Cd28 antibody (BioXcell, 37.51) was used in blocking or activating experiments on mouse samples at 1 ug/ml (fig 3a). Biomolecules (2020) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...; fig 2h
Bio X Cell Cd28 antibody (BioXCell, 37.51) was used in blocking or activating experiments on mouse samples (fig 2h). Science (2019) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...; fig 5b, 6a
Bio X Cell Cd28 antibody (Bio X Cell, 37.51) was used in blocking or activating experiments on mouse samples (fig 5b, 6a). J Exp Med (2019) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; 10 ug/ml; loading ...
Bio X Cell Cd28 antibody (Bio X Cell, 37.51) was used in blocking or activating experiments on mouse samples at 10 ug/ml. J Clin Invest (2019) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; 2 ug/ml; loading ...; fig s3a
Bio X Cell Cd28 antibody (Bio X Cell, 37.51) was used in blocking or activating experiments on mouse samples at 2 ug/ml (fig s3a). Nature (2019) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; 10 ug/ml; loading ...; fig 4a
Bio X Cell Cd28 antibody (BioXcell, 37.51) was used in blocking or activating experiments on mouse samples at 10 ug/ml (fig 4a). J Clin Invest (2018) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; 2 ug/ml; fig 1a
Bio X Cell Cd28 antibody (BioXcell, 37.51) was used in blocking or activating experiments on mouse samples at 2 ug/ml (fig 1a). Cancer Immunol Immunother (2019) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...; fig s1b
Bio X Cell Cd28 antibody (BioXcell, 37.51) was used in blocking or activating experiments on mouse samples (fig s1b). Science (2016) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...; fig s4a
In order to elucidate the molecular mechanisms that regulate doxorubicin-mediated cell death of myeloid-derived suppressor cells, Bio X Cell Cd28 antibody (BioXcell, 37.51) was used in blocking or activating experiments on mouse samples (fig s4a). Oncogene (2017) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; human; loading ...
In order to investigate the contribution of NLRP3 inflammasome activity to the T helper cell 1 response, Bio X Cell Cd28 antibody (Bio X cell, 37.51) was used in blocking or activating experiments on human samples . Science (2016) ncbi
Syrian golden hamster monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...; fig 4a
Bio X Cell Cd28 antibody (BioXCell, 37.51) was used in blocking or activating experiments on mouse samples (fig 4a). Immunity (2015) ncbi
Abcam
rat monoclonal (RM0386-17E9)
  • blocking or activating experiments; mouse; 5 ug/ml; loading ...; fig 7d
Abcam Cd28 antibody (Abcam, ab205136) was used in blocking or activating experiments on mouse samples at 5 ug/ml (fig 7d). Nucleic Acids Res (2021) ncbi
rat monoclonal (RM0386-17E9)
  • western blot; mouse; 1:1000; loading ...; fig 6c
Abcam Cd28 antibody (Abcam, ab205136) was used in western blot on mouse samples at 1:1000 (fig 6c). Nat Commun (2018) ncbi
hamsters monoclonal (PV-1)
  • western blot; human
In order to describe a method to generate bispecific antibodies, Abcam Cd28 antibody (Abcam, ab25234) was used in western blot on human samples . Nat Commun (2015) ncbi
Santa Cruz Biotechnology
Syrian golden hamster monoclonal (37.51.1)
  • blocking or activating experiments; human
Santa Cruz Biotechnology Cd28 antibody (Santa Cruz, sc-12727) was used in blocking or activating experiments on human samples . PLoS ONE (2014) ncbi
Exbio
mouse monoclonal (CD28.2)
  • flow cytometry; human; loading ...; fig 3a
Exbio Cd28 antibody (Exbio, CD28.2) was used in flow cytometry on human samples (fig 3a). J Virol (2018) ncbi
BD Biosciences
hamsters monoclonal (37.51)
  • blocking or activating experiments; mouse; 2 ug/ml; loading ...; fig 6b
BD Biosciences Cd28 antibody (BD Pharmingen, 37.51) was used in blocking or activating experiments on mouse samples at 2 ug/ml (fig 6b). JCI Insight (2021) ncbi
hamsters monoclonal (37.51)
  • blocking or activating experiments; mouse; 2 ug/ml; loading ...; fig 4a
BD Biosciences Cd28 antibody (BD, 553294) was used in blocking or activating experiments on mouse samples at 2 ug/ml (fig 4a). Aging (Albany NY) (2020) ncbi
hamsters monoclonal (37.51)
  • blocking or activating experiments; mouse; 4 ug/ml; loading ...; fig 2i
BD Biosciences Cd28 antibody (BD Pharmingen, 37.51) was used in blocking or activating experiments on mouse samples at 4 ug/ml (fig 2i). Science (2020) ncbi
hamsters monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...; fig 9a
In order to investigate the role of Egr2 and 3 in adaptive immune responses and its mechanism, BD Biosciences Cd28 antibody (BD, 557393) was used in blocking or activating experiments on mouse samples (fig 9a). J Exp Med (2017) ncbi
hamsters monoclonal (37.51)
  • flow cytometry; mouse; loading ...; fig 1a
BD Biosciences Cd28 antibody (BD Biosciences, 37.51) was used in flow cytometry on mouse samples (fig 1a). J Immunol (2017) ncbi
hamsters monoclonal (37.51)
  • flow cytometry; mouse
In order to investigate the mechanisms by which eomesodermin regulates memory fitness in T cells, BD Biosciences Cd28 antibody (BD Pharmingen, 37.51) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2017) ncbi
hamsters monoclonal (37.51)
  • blocking or activating experiments; mouse; 1 ug/ml; loading ...
In order to test the effect of paeoniflorin in experimental autoimmune encephalomyelitis, an animal model for multiple sclerosis, BD Biosciences Cd28 antibody (BD biosciences, 553294) was used in blocking or activating experiments on mouse samples at 1 ug/ml. Sci Rep (2017) ncbi
hamsters monoclonal (37.51)
  • other; mouse; loading ...; fig 1c
BD Biosciences Cd28 antibody (BD, 37.51) was used in other on mouse samples (fig 1c). J Clin Invest (2017) ncbi
hamsters monoclonal (37.51)
  • other; mouse; 2 ug/ml; loading ...; fig 4
BD Biosciences Cd28 antibody (BD Biosciences, 553295) was used in other on mouse samples at 2 ug/ml (fig 4). Sci Rep (2017) ncbi
hamsters monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...; fig s1
In order to show that ABCA7 regulates natural killer T cell development in a cell-extrinsic manner, BD Biosciences Cd28 antibody (BD Bioscience, 37.51) was used in blocking or activating experiments on mouse samples (fig s1). Sci Rep (2017) ncbi
hamsters monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...
In order to assess the role of p38 signaling in limiting regulatory T cell induction, BD Biosciences Cd28 antibody (BD, 37.51) was used in blocking or activating experiments on mouse samples . J Biol Chem (2017) ncbi
hamsters monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...; fig s3c
BD Biosciences Cd28 antibody (BD Pharmingen, 37.51) was used in blocking or activating experiments on mouse samples (fig s3c). Proc Natl Acad Sci U S A (2016) ncbi
hamsters monoclonal (37.51)
  • flow cytometry; mouse; loading ...; fig 5c
In order to study the role of PD-1 and Tim-3 crosstalk in the regulation of antitumor T cell responses, BD Biosciences Cd28 antibody (Biolegend, 553296) was used in flow cytometry on mouse samples (fig 5c). Oncoimmunology (2016) ncbi
hamsters monoclonal (37.51)
  • blocking or activating experiments; mouse; 4 ug/ml; loading ...
BD Biosciences Cd28 antibody (BD Pharmingen, 37.51) was used in blocking or activating experiments on mouse samples at 4 ug/ml. Science (2016) ncbi
hamsters monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...
In order to demonstrate that targeting a truncated version of the epidermal growth factor receptor with cetuximab eliminates CD19 chimeric antigen receptor T cells, BD Biosciences Cd28 antibody (BD Pharmingen, 37.51) was used in blocking or activating experiments on mouse samples . J Clin Invest (2016) ncbi
hamsters monoclonal (37.51)
  • flow cytometry; human; fig 1
In order to explore the role of GABAergic signaling in mesenchymal stem cell-mediated immunosuppression, BD Biosciences Cd28 antibody (BD Biosciences, 553294) was used in flow cytometry on human samples (fig 1). PLoS ONE (2016) ncbi
hamsters monoclonal (37.51)
  • blocking or activating experiments; mouse; 1 ug/ml; loading ...
In order to discuss methods to improve needle-free intradermal injections, BD Biosciences Cd28 antibody (BD Biosciences, 553295) was used in blocking or activating experiments on mouse samples at 1 ug/ml. Sci Rep (2016) ncbi
hamsters monoclonal (37.51)
  • flow cytometry; mouse; loading ...; fig 1a, 1b, 1c
In order to explore signaling pathways regulated by RLTPR in T and B cells, BD Biosciences Cd28 antibody (BD, 37.51) was used in flow cytometry on mouse samples (fig 1a, 1b, 1c). J Exp Med (2016) ncbi
hamsters monoclonal (37.51)
  • immunocytochemistry; mouse
BD Biosciences Cd28 antibody (BD, 37.51) was used in immunocytochemistry on mouse samples . PLoS Pathog (2016) ncbi
hamsters monoclonal (37.51)
  • blocking or activating experiments; mouse; fig 3d
In order to investigate osmostress-dependent and -independent functions of Nfat5 in T cells, BD Biosciences Cd28 antibody (BD Biosciences, 553295) was used in blocking or activating experiments on mouse samples (fig 3d). Immunol Cell Biol (2017) ncbi
hamsters monoclonal (37.51)
  • blocking or activating experiments; mouse; 1 ug/ml; fig 3
BD Biosciences Cd28 antibody (BD Pharmingen, 553295) was used in blocking or activating experiments on mouse samples at 1 ug/ml (fig 3). Mol Med Rep (2016) ncbi
hamsters monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...; fig 3b
In order to find that coagulation factor XII modulates immune responses, BD Biosciences Cd28 antibody (BD Biosciences, 37.51) was used in blocking or activating experiments on mouse samples (fig 3b). Nat Commun (2016) ncbi
hamsters monoclonal (37.51)
  • flow cytometry; mouse; 2 ug/ml
BD Biosciences Cd28 antibody (Becton Dickinson, 37.51) was used in flow cytometry on mouse samples at 2 ug/ml. Nature (2016) ncbi
hamsters monoclonal (37.51)
  • blocking or activating experiments; mouse; 0.25 ug/ml
In order to study how focused, low-intensity ultrasound can reverse tumor-induced T cell tolerance and prevent immune escape, BD Biosciences Cd28 antibody (BD Biosciences, 37.51) was used in blocking or activating experiments on mouse samples at 0.25 ug/ml. J Immunol (2016) ncbi
hamsters monoclonal (37.51)
  • blocking or activating experiments; mouse; loading ...
BD Biosciences Cd28 antibody (BD Biosciences, 553294) was used in blocking or activating experiments on mouse samples . Sci Rep (2016) ncbi
hamsters monoclonal (37.51)
  • blocking or activating experiments; mouse; fig 1
In order to investigate the control of LAT recruitment to the immune synapse and T-cell activation in vivo by IFT20, BD Biosciences Cd28 antibody (BD Pharmingen, 553294) was used in blocking or activating experiments on mouse samples (fig 1). Proc Natl Acad Sci U S A (2016) ncbi
hamsters monoclonal (37.51)
  • blocking or activating experiments; mouse; fig 3i
BD Biosciences Cd28 antibody (BD Pharmingen, 37.51) was used in blocking or activating experiments on mouse samples (fig 3i). Nat Med (2015) ncbi
hamsters monoclonal (37.51)
  • blocking or activating experiments; mouse; 5 mg/ml; loading ...; fig 1a
BD Biosciences Cd28 antibody (BD Pharmingen Biosciences, 37.51) was used in blocking or activating experiments on mouse samples at 5 mg/ml (fig 1a). PLoS ONE (2015) ncbi
hamsters monoclonal (37.51)
  • blocking or activating experiments; mouse; fig 2
BD Biosciences Cd28 antibody (BD, 553295) was used in blocking or activating experiments on mouse samples (fig 2). PLoS ONE (2015) ncbi
hamsters monoclonal (37.51)
  • blocking or activating experiments; mouse; 2 ug/ml
BD Biosciences Cd28 antibody (BD Pharmingen, 553294) was used in blocking or activating experiments on mouse samples at 2 ug/ml. Stem Cell Res Ther (2015) ncbi
hamsters monoclonal (37.51)
  • blocking or activating experiments; mouse
In order to identify DUBA as a suppressor of IL-17 production in T cells, BD Biosciences Cd28 antibody (BD, 37.51) was used in blocking or activating experiments on mouse samples . Nature (2015) ncbi
hamsters monoclonal (37.51)
  • blocking or activating experiments; mouse; 10 ug/ml; fig 2
In order to analyze deubiquitinization Usp9X and its regulation of proximal T cell receptor signaling and tolerance induction, BD Biosciences Cd28 antibody (BD, 37.51) was used in blocking or activating experiments on mouse samples at 10 ug/ml (fig 2). J Exp Med (2014) ncbi
hamsters monoclonal (37.51)
  • blocking or activating experiments; human; 1 ug/ml
  • blocking or activating experiments; mouse; 1 ug/ml
In order to study the effect of atorvastatin on telomerase activity in peripheral blood mononuclear cells and T-lymphocytes, BD Biosciences Cd28 antibody (BD, 553295) was used in blocking or activating experiments on human samples at 1 ug/ml and in blocking or activating experiments on mouse samples at 1 ug/ml. Atherosclerosis (2014) ncbi
hamsters monoclonal (37.51)
  • flow cytometry; mouse
BD Biosciences Cd28 antibody (BD Biosciences, 37.51) was used in flow cytometry on mouse samples . J Mol Cell Cardiol (2014) ncbi
hamsters monoclonal (37.51)
  • blocking or activating experiments; mouse; 1 ug/ml
BD Biosciences Cd28 antibody (BD Pharmingen, 37.51) was used in blocking or activating experiments on mouse samples at 1 ug/ml. PLoS ONE (2014) ncbi
hamsters monoclonal (37.51)
  • blocking or activating experiments; mouse
BD Biosciences Cd28 antibody (BD PharMingen, 37.51) was used in blocking or activating experiments on mouse samples . Immunol Cell Biol (2014) ncbi
hamsters monoclonal (37.51)
  • immunohistochemistry; mouse; 1:500
BD Biosciences Cd28 antibody (BD, 553295) was used in immunohistochemistry on mouse samples at 1:500. PLoS ONE (2014) ncbi
hamsters monoclonal (37.51)
  • blocking or activating experiments; mouse; 0.5 ug/ml
In order to study the effect of FTY720 treatment on CD8 T-cells, BD Biosciences Cd28 antibody (BD Biosciences, 37.51) was used in blocking or activating experiments on mouse samples at 0.5 ug/ml. J Neuroimmunol (2014) ncbi
hamsters monoclonal (37.51)
  • blocking or activating experiments; mouse; 1 ug/ml
BD Biosciences Cd28 antibody (BD, 553295) was used in blocking or activating experiments on mouse samples at 1 ug/ml. PLoS ONE (2014) ncbi
hamsters monoclonal (37.51)
  • blocking or activating experiments; mouse; 2 ug/ml
BD Biosciences Cd28 antibody (BD Biosciences, 37.51) was used in blocking or activating experiments on mouse samples at 2 ug/ml. J Immunol (2014) ncbi
hamsters monoclonal (37.51)
  • blocking or activating experiments; mouse; 1 ug/ml
BD Biosciences Cd28 antibody (BD Biosciences, 37.51) was used in blocking or activating experiments on mouse samples at 1 ug/ml. Int Immunol (2014) ncbi
hamsters monoclonal (37.51)
  • blocking or activating experiments; mouse; 10 ug/ml
BD Biosciences Cd28 antibody (BD Pharmingen, 37.51) was used in blocking or activating experiments on mouse samples at 10 ug/ml. J Immunol (2013) ncbi
hamsters monoclonal (37.51)
  • blocking or activating experiments; mouse; 1 ug/ml; fig 2
BD Biosciences Cd28 antibody (BD Pharmingen, 553294) was used in blocking or activating experiments on mouse samples at 1 ug/ml (fig 2). Cell Commun Signal (2011) ncbi
Articles Reviewed
  1. Liu H, Pedros C, Kong K, Canonigo Balancio A, Xue W, Altman A. Leveraging the Treg-intrinsic CTLA4-PKCη signaling pathway for cancer immunotherapy. J Immunother Cancer. 2021;9: pubmed publisher
  2. Uyanik B, Goloudina A, Akbarali A, Grigorash B, Petukhov A, Singhal S, et al. Inhibition of the DNA damage response phosphatase PPM1D reprograms neutrophils to enhance anti-tumor immune responses. Nat Commun. 2021;12:3622 pubmed publisher
  3. Kim C, Park S, Lee S, Kim Y, Jang S, Woo S, et al. NSrp70 is a lymphocyte-essential splicing factor that controls thymocyte development. Nucleic Acids Res. 2021;49:5760-5778 pubmed publisher
  4. Glassman C, Su L, Majri Morrison S, Winkelmann H, Mo F, Li P, et al. Calibration of cell-intrinsic interleukin-2 response thresholds guides design of a regulatory T cell biased agonist. elife. 2021;10: pubmed publisher
  5. Akgul A, Maddaloni M, Jun S, Nelson A, Odreman V, Hoffman C, et al. Stimulation of regulatory T cells with Lactococcus lactis expressing enterotoxigenic E. coli colonization factor antigen 1 retains salivary flow in a genetic model of Sjögren's syndrome. Arthritis Res Ther. 2021;23:99 pubmed publisher
  6. Voisin M, Shrestha E, Rollet C, Nikain C, Josefs T, Mahe M, et al. Inhibiting LXRα phosphorylation in hematopoietic cells reduces inflammation and attenuates atherosclerosis and obesity in mice. Commun Biol. 2021;4:420 pubmed publisher
  7. Petty A, Dai R, Lapalombella R, Baiocchi R, Benson D, Li Z, et al. Hedgehog-induced PD-L1 on tumor-associated macrophages is critical for suppression of tumor-infiltrating CD8+ T cell function. JCI Insight. 2021;6: pubmed publisher
  8. Nian Y, Iske J, Maenosono R, Minami K, Heinbokel T, Quante M, et al. Targeting age-specific changes in CD4+ T cell metabolism ameliorates alloimmune responses and prolongs graft survival. Aging Cell. 2021;20:e13299 pubmed publisher
  9. Zhao L, Hu S, Davila M, Yang J, Lin Y, Albanese J, et al. Coordinated co-migration of CCR10+ antibody-producing B cells with helper T cells for colonic homeostatic regulation. Mucosal Immunol. 2021;14:420-430 pubmed publisher
  10. Pasciuto E, Burton O, Roca C, Lagou V, Rajan W, Theys T, et al. Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition. Cell. 2020;182:625-640.e24 pubmed publisher
  11. Gryzik S, Hoang Y, Lischke T, Mohr E, Venzke M, Kadner I, et al. Identification of a super-functional Tfh-like subpopulation in murine lupus by pattern perception. elife. 2020;9: pubmed publisher
  12. Cai L, Chao G, Li W, Zhu J, Li F, Qi B, et al. Activated CD4+ T cells-derived exosomal miR-142-3p boosts post-ischemic ventricular remodeling by activating myofibroblast. Aging (Albany NY). 2020;12:7380-7396 pubmed publisher
  13. Wang J, Li P, Yu Y, Fu Y, Jiang H, Lu M, et al. Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity. Science. 2020;367: pubmed publisher
  14. Chen H, Cong X, Wu C, Wu X, Wang J, Mao K, et al. Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9+ T cells. Sci Adv. 2020;6:eaax4690 pubmed publisher
  15. Canel M, Taggart D, Sims A, Lonergan D, Waizenegger I, Serrels A. T-cell co-stimulation in combination with targeting FAK drives enhanced anti-tumor immunity. elife. 2020;9: pubmed publisher
  16. Park Y, Cho M, Choi G, Na H, Chung Y. A Critical Regulation of Th17 Cell Responses and Autoimmune Neuro-Inflammation by Ginsenoside Rg3. Biomolecules. 2020;10: pubmed publisher
  17. Shi L, Wang J, Ding N, Zhang Y, Zhu Y, Dong S, et al. Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy. Nat Commun. 2019;10:5421 pubmed publisher
  18. Leone R, Zhao L, Englert J, Sun I, Oh M, Sun I, et al. Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion. Science. 2019;366:1013-1021 pubmed publisher
  19. Krovi S, Kappler J, Marrack P, Gapin L. Inherent reactivity of unselected TCR repertoires to peptide-MHC molecules. Proc Natl Acad Sci U S A. 2019;116:22252-22261 pubmed publisher
  20. Rasoulouniriana D, Santana Magal N, Gutwillig A, Farhat Younis L, Wine Y, Saperia C, et al. A distinct subset of FcγRI-expressing Th1 cells exert antibody-mediated cytotoxic activity. J Clin Invest. 2019;129:4151-4164 pubmed publisher
  21. Humeniuk P, Geiselhart S, Battin C, Webb T, Steinberger P, Paster W, et al. Generation of a Jurkat-based fluorescent reporter cell line to evaluate lipid antigen interaction with the human iNKT cell receptor. Sci Rep. 2019;9:7426 pubmed publisher
  22. Kotov J, Kotov D, Linehan J, Bardwell V, Gearhart M, Jenkins M. BCL6 corepressor contributes to Th17 cell formation by inhibiting Th17 fate suppressors. J Exp Med. 2019;216:1450-1464 pubmed publisher
  23. Xing S, Gai K, Li X, Shao P, Zeng Z, Zhao X, et al. Tcf1 and Lef1 are required for the immunosuppressive function of regulatory T cells. J Exp Med. 2019;: pubmed publisher
  24. Anandagoda N, Willis J, Hertweck A, Roberts L, Jackson I, Gökmen M, et al. microRNA-142-mediated repression of phosphodiesterase 3B critically regulates peripheral immune tolerance. J Clin Invest. 2019;129:1257-1271 pubmed publisher
  25. Karmaus P, Chen X, Lim S, Herrada A, Nguyen T, Xu B, et al. Metabolic heterogeneity underlies reciprocal fates of TH17 cell stemness and plasticity. Nature. 2019;565:101-105 pubmed publisher
  26. Muscate F, Stetter N, Schramm C, Schulze zur Wiesch J, Bosurgi L, Jacobs T. HVEM and CD160: Regulators of Immunopathology During Malaria Blood-Stage. Front Immunol. 2018;9:2611 pubmed publisher
  27. Klement J, Paschall A, Redd P, Ibrahim M, Lu C, Yang D, et al. An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion. J Clin Invest. 2018;128:5549-5560 pubmed publisher
  28. Singh A, Khare P, Obaid A, Conlon K, Basrur V, Depinho R, et al. SUMOylation of ROR-γt inhibits IL-17 expression and inflammation via HDAC2. Nat Commun. 2018;9:4515 pubmed publisher
  29. Qiao G, Bucsek M, Winder N, Chen M, Giridharan T, Olejniczak S, et al. β-Adrenergic signaling blocks murine CD8+ T-cell metabolic reprogramming during activation: a mechanism for immunosuppression by adrenergic stress. Cancer Immunol Immunother. 2019;68:11-22 pubmed publisher
  30. Kim H, Mun Y, Lee K, Park Y, Park J, Park J, et al. T cell microvilli constitute immunological synaptosomes that carry messages to antigen-presenting cells. Nat Commun. 2018;9:3630 pubmed publisher
  31. Stathopoulou C, Gangaplara A, Mallett G, Flomerfelt F, Liniany L, Knight D, et al. PD-1 Inhibitory Receptor Downregulates Asparaginyl Endopeptidase and Maintains Foxp3 Transcription Factor Stability in Induced Regulatory T Cells. Immunity. 2018;49:247-263.e7 pubmed publisher
  32. Gisterå A, Klement M, Polyzos K, Mailer R, Duhlin A, Karlsson M, et al. LDL-Reactive T Cells Regulate Plasma Cholesterol Levels and Development of Atherosclerosis in Humanized Hypercholesterolemic Mice. Circulation. 2018;: pubmed publisher
  33. Prado C, Gaiazzi M, Gonzalez H, Ugalde V, Figueroa A, Osorio Barrios F, et al. Dopaminergic Stimulation of Myeloid Antigen-Presenting Cells Attenuates Signal Transducer and Activator of Transcription 3-Activation Favouring the Development of Experimental Autoimmune Encephalomyelitis. Front Immunol. 2018;9:571 pubmed publisher
  34. Kishore M, Cheung K, Fu H, Bonacina F, Wang G, Coe D, et al. Regulatory T Cell Migration Is Dependent on Glucokinase-Mediated Glycolysis. Immunity. 2017;47:875-889.e10 pubmed publisher
  35. Moreno Cubero E, Subira D, Sanz de Villalobos E, Parra Cid T, Madejon A, Miquel J, et al. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1low HCV-Specific CD8+ Cell Reactivity. J Virol. 2018;92: pubmed publisher
  36. Lingel H, Wissing J, Arra A, Schanze D, Lienenklaus S, Klawonn F, et al. CTLA-4-mediated posttranslational modifications direct cytotoxic T-lymphocyte differentiation. Cell Death Differ. 2017;24:1739-1749 pubmed publisher
  37. Miao T, Symonds A, Singh R, Symonds J, Ogbe A, Omodho B, et al. Egr2 and 3 control adaptive immune responses by temporally uncoupling expansion from T cell differentiation. J Exp Med. 2017;214:1787-1808 pubmed publisher
  38. Singh R, Miao T, Symonds A, Omodho B, Li S, Wang P. Egr2 and 3 Inhibit T-bet-Mediated IFN-? Production in T Cells. J Immunol. 2017;198:4394-4402 pubmed publisher
  39. Fu G, Xu Q, Qiu Y, Jin X, Xu T, Dong S, et al. Suppression of Th17 cell differentiation by misshapen/NIK-related kinase MINK1. J Exp Med. 2017;214:1453-1469 pubmed publisher
  40. Martinez Jimenez C, Eling N, Chen H, Vallejos C, Kolodziejczyk A, Connor F, et al. Aging increases cell-to-cell transcriptional variability upon immune stimulation. Science. 2017;355:1433-1436 pubmed publisher
  41. González Pérez G, Lamousé Smith E. Gastrointestinal Microbiome Dysbiosis in Infant Mice Alters Peripheral CD8+ T Cell Receptor Signaling. Front Immunol. 2017;8:265 pubmed publisher
  42. Klein J, Moses K, Zelinskyy G, Sody S, Buer J, Lang S, et al. Combined toll-like receptor 3/7/9 deficiency on host cells results in T-cell-dependent control of tumour growth. Nat Commun. 2017;8:14600 pubmed publisher
  43. Wang H, Mo L, Xiao X, An S, Liu X, Ba J, et al. Pplase of Dermatophagoides farinae promotes ovalbumin-induced airway allergy by modulating the functions of dendritic cells in a mouse model. Sci Rep. 2017;7:43322 pubmed publisher
  44. Knudson K, Pritzl C, Saxena V, Altman A, Daniels M, Teixeiro E. NFκB-Pim-1-Eomesodermin axis is critical for maintaining CD8 T-cell memory quality. Proc Natl Acad Sci U S A. 2017;114:E1659-E1667 pubmed publisher
  45. Zhang H, Qi Y, Yuan Y, Cai L, Xu H, Zhang L, et al. Paeoniflorin Ameliorates Experimental Autoimmune Encephalomyelitis via Inhibition of Dendritic Cell Function and Th17 Cell Differentiation. Sci Rep. 2017;7:41887 pubmed publisher
  46. Beavis P, Henderson M, Giuffrida L, Mills J, Sek K, Cross R, et al. Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy. J Clin Invest. 2017;127:929-941 pubmed publisher
  47. Hwang I, Kim K, Choi S, Lomunova M. Potentiation of T Cell Stimulatory Activity by Chemical Fixation of a Weak Peptide-MHC Complex. Mol Cells. 2017;40:24-36 pubmed publisher
  48. Seo W, Muroi S, Akiyama K, Taniuchi I. Distinct requirement of Runx complexes for TCRβ enhancer activation at distinct developmental stages. Sci Rep. 2017;7:41351 pubmed publisher
  49. Vähätupa M, Aittomaki S, Martinez Cordova Z, May U, Prince S, Uusitalo Jarvinen H, et al. T-cell-expressed proprotein convertase FURIN inhibits DMBA/TPA-induced skin cancer development. Oncoimmunology. 2016;5:e1245266 pubmed publisher
  50. Nowyhed H, Chandra S, Kiosses W, Marcovecchio P, Andary F, Zhao M, et al. ATP Binding Cassette Transporter ABCA7 Regulates NKT Cell Development and Function by Controlling CD1d Expression and Lipid Raft Content. Sci Rep. 2017;7:40273 pubmed publisher
  51. Troegeler A, Mercier I, Cougoule C, Pietretti D, Colom A, Duval C, et al. C-type lectin receptor DCIR modulates immunity to tuberculosis by sustaining type I interferon signaling in dendritic cells. Proc Natl Acad Sci U S A. 2017;114:E540-E549 pubmed publisher
  52. Blanquiceth Y, Rodríguez Perea A, Tabares Guevara J, Correa L, Sánchez M, Ramirez Pineda J, et al. Increase of Frequency and Modulation of Phenotype of Regulatory T Cells by Atorvastatin Is Associated with Decreased Lung Inflammatory Cell Infiltration in a Murine Model of Acute Allergic Asthma. Front Immunol. 2016;7:620 pubmed publisher
  53. Araujo L, Khim P, Mkhikian H, Mortales C, Demetriou M. Glycolysis and glutaminolysis cooperatively control T cell function by limiting metabolite supply to N-glycosylation. elife. 2017;6: pubmed publisher
  54. Kinosada H, Yasunaga J, Shimura K, Miyazato P, Onishi C, Iyoda T, et al. HTLV-1 bZIP Factor Enhances T-Cell Proliferation by Impeding the Suppressive Signaling of Co-inhibitory Receptors. PLoS Pathog. 2017;13:e1006120 pubmed publisher
  55. Hayakawa M, Hayakawa H, Petrova T, Ritprajak P, Sutavani R, Jiménez Andrade G, et al. Loss of Functionally Redundant p38 Isoforms in T Cells Enhances Regulatory T Cell Induction. J Biol Chem. 2017;292:1762-1772 pubmed publisher
  56. Karki R, Man S, Malireddi R, Kesavardhana S, Zhu Q, Burton A, et al. NLRC3 is an inhibitory sensor of PI3K-mTOR pathways in cancer. Nature. 2016;540:583-587 pubmed publisher
  57. Bieber K, Witte M, Sun S, Hundt J, Kalies K, Dräger S, et al. T cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisita. Sci Rep. 2016;6:38357 pubmed publisher
  58. Angela M, Endo Y, Asou H, Yamamoto T, Tumes D, Tokuyama H, et al. Fatty acid metabolic reprogramming via mTOR-mediated inductions of PPAR? directs early activation of T cells. Nat Commun. 2016;7:13683 pubmed publisher
  59. Cecchinato V, Bernasconi E, Speck R, Proietti M, Sauermann U, D Agostino G, et al. Impairment of CCR6+ and CXCR3+ Th Cell Migration in HIV-1 Infection Is Rescued by Modulating Actin Polymerization. J Immunol. 2017;198:184-195 pubmed
  60. Hammer A, Yang G, Friedrich J, Kovacs A, Lee D, Grave K, et al. Role of the receptor Mas in macrophage-mediated inflammation in vivo. Proc Natl Acad Sci U S A. 2016;113:14109-14114 pubmed
  61. Li J, Shayan G, Avery L, Jie H, Gildener Leapman N, Schmitt N, et al. Tumor-infiltrating Tim-3+ T cells proliferate avidly except when PD-1 is co-expressed: Evidence for intracellular cross talk. Oncoimmunology. 2016;5:e1200778 pubmed
  62. Sen D, Kaminski J, Barnitz R, Kurachi M, Gerdemann U, Yates K, et al. The epigenetic landscape of T cell exhaustion. Science. 2016;354:1165-1169 pubmed
  63. Paszkiewicz P, Fräßle S, Srivastava S, Sommermeyer D, Hudecek M, Drexler I, et al. Targeted antibody-mediated depletion of murine CD19 CAR T cells permanently reverses B cell aplasia. J Clin Invest. 2016;126:4262-4272 pubmed publisher
  64. Massaad M, Zhou J, Tsuchimoto D, Chou J, Jabara H, Janssen E, et al. Deficiency of base excision repair enzyme NEIL3 drives increased predisposition to autoimmunity. J Clin Invest. 2016;126:4219-4236 pubmed publisher
  65. Peng M, Yin N, Chhangawala S, Xu K, Leslie C, Li M. Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism. Science. 2016;354:481-484 pubmed
  66. Urrutia M, Fernandez S, Gonzalez M, Vilches R, Rojas P, Vásquez M, et al. Overexpression of Glutamate Decarboxylase in Mesenchymal Stem Cells Enhances Their Immunosuppressive Properties and Increases GABA and Nitric Oxide Levels. PLoS ONE. 2016;11:e0163735 pubmed publisher
  67. Arunachalam P, Mishra R, Badarinath K, Selvam D, Payeli S, Stout R, et al. Toll-Like Receptor 9 Activation Rescues Impaired Antibody Response in Needle-free Intradermal DNA Vaccination. Sci Rep. 2016;6:33564 pubmed publisher
  68. Roncagalli R, Cucchetti M, Jarmuzynski N, Gregoire C, Bergot E, Audebert S, et al. The scaffolding function of the RLTPR protein explains its essential role for CD28 co-stimulation in mouse and human T cells. J Exp Med. 2016;213:2437-2457 pubmed
  69. Lexmond W, Goettel J, Lyons J, Jacobse J, Deken M, Lawrence M, et al. FOXP3+ Tregs require WASP to restrain Th2-mediated food allergy. J Clin Invest. 2016;126:4030-4044 pubmed publisher
  70. Eil R, Vodnala S, Clever D, Klebanoff C, Sukumar M, Pan J, et al. Ionic immune suppression within the tumour microenvironment limits T cell effector function. Nature. 2016;537:539-543 pubmed publisher
  71. Janssen E, Tohme M, Hedayat M, Leick M, Kumari S, Ramesh N, et al. A DOCK8-WIP-WASp complex links T cell receptors to the actin cytoskeleton. J Clin Invest. 2016;126:3837-3851 pubmed publisher
  72. Ishikura S, Tsunoda T, Nakabayashi K, Doi K, Koyanagi M, Hayashi K, et al. Molecular mechanisms of transcriptional regulation by the nuclear zinc-finger protein Zfat in T cells. Biochim Biophys Acta. 2016;1859:1398-1410 pubmed publisher
  73. Kuwahara M, Ise W, Ochi M, Suzuki J, Kometani K, Maruyama S, et al. Bach2-Batf interactions control Th2-type immune response by regulating the IL-4 amplification loop. Nat Commun. 2016;7:12596 pubmed publisher
  74. Wang H, Li M, Hung C, Sinha M, Lee L, Wiesner D, et al. MyD88 Shapes Vaccine Immunity by Extrinsically Regulating Survival of CD4+ T Cells during the Contraction Phase. PLoS Pathog. 2016;12:e1005787 pubmed publisher
  75. Alberdi M, Iglesias M, Tejedor S, Merino R, Lopez Rodriguez C, Aramburu J. Context-dependent regulation of Th17-associated genes and IFN? expression by the transcription factor NFAT5. Immunol Cell Biol. 2017;95:56-67 pubmed publisher
  76. Weiss J, Chen W, Nyuydzefe M, Trzeciak A, Flynn R, Tonra J, et al. ROCK2 signaling is required to induce a subset of T follicular helper cells through opposing effects on STATs in autoimmune settings. Sci Signal. 2016;9:ra73 pubmed publisher
  77. Xu Y, Zhao F, Qiu Q, Chen K, Wei J, Kong Q, et al. The ER membrane-anchored ubiquitin ligase Hrd1 is a positive regulator of T-cell immunity. Nat Commun. 2016;7:12073 pubmed publisher
  78. Terracina K, Graham L, Payne K, Manjili M, Baek A, Damle S, et al. DNA methyltransferase inhibition increases efficacy of adoptive cellular immunotherapy of murine breast cancer. Cancer Immunol Immunother. 2016;65:1061-73 pubmed publisher
  79. Deng Z, Rong Y, Teng Y, Zhuang X, Samykutty A, Mu J, et al. Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis. Oncogene. 2017;36:639-651 pubmed publisher
  80. Stentzel S, Teufelberger A, Nordengrün M, Kolata J, Schmidt F, Van Crombruggen K, et al. Staphylococcal serine protease-like proteins are pacemakers of allergic airway reactions to Staphylococcus aureus. J Allergy Clin Immunol. 2017;139:492-500.e8 pubmed publisher
  81. Gu L, Deng W, Sun X, Zhou H, Xu Q. Rapamycin ameliorates CCl4-induced liver fibrosis in mice through reciprocal regulation of the Th17/Treg cell balance. Mol Med Rep. 2016;14:1153-61 pubmed publisher
  82. Arbore G, West E, Spolski R, Robertson A, Klos A, Rheinheimer C, et al. T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4⁺ T cells. Science. 2016;352:aad1210 pubmed publisher
  83. Göbel K, Pankratz S, Asaridou C, Herrmann A, Bittner S, Merker M, et al. Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells. Nat Commun. 2016;7:11626 pubmed publisher
  84. Contreras F, Prado C, Gonzalez H, Franz D, Osorio Barrios F, Osorio F, et al. Dopamine Receptor D3 Signaling on CD4+ T Cells Favors Th1- and Th17-Mediated Immunity. J Immunol. 2016;196:4143-9 pubmed publisher
  85. Swamy M, Pathak S, Grzes K, Damerow S, Sinclair L, van Aalten D, et al. Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancy. Nat Immunol. 2016;17:712-20 pubmed publisher
  86. Oudhoff M, Braam M, Freeman S, Wong D, Rattray D, Wang J, et al. SETD7 Controls Intestinal Regeneration and Tumorigenesis by Regulating Wnt/?-Catenin and Hippo/YAP Signaling. Dev Cell. 2016;37:47-57 pubmed publisher
  87. Martin B, Wang C, Zhang C, Kang Z, Gulen M, Zepp J, et al. T cell-intrinsic ASC critically promotes T(H)17-mediated experimental autoimmune encephalomyelitis. Nat Immunol. 2016;17:583-92 pubmed publisher
  88. Ravindran R, Loebbermann J, Nakaya H, Khan N, Ma H, Gama L, et al. The amino acid sensor GCN2 controls gut inflammation by inhibiting inflammasome activation. Nature. 2016;531:523-527 pubmed publisher
  89. Apostolidis S, Rodríguez Rodríguez N, Suárez Fueyo A, Dioufa N, Ozcan E, Crispín J, et al. Phosphatase PP2A is requisite for the function of regulatory T cells. Nat Immunol. 2016;17:556-64 pubmed publisher
  90. Seifert L, Werba G, Tiwari S, Giao Ly N, Nguy S, Alothman S, et al. Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in Mice. Gastroenterology. 2016;150:1659-1672.e5 pubmed publisher
  91. Kabat A, Harrison O, Riffelmacher T, Moghaddam A, Pearson C, Laing A, et al. The autophagy gene Atg16l1 differentially regulates Treg and TH2 cells to control intestinal inflammation. elife. 2016;5:e12444 pubmed publisher
  92. Hu H, Wang H, Xiao Y, Jin J, Chang J, Zou Q, et al. Otud7b facilitates T cell activation and inflammatory responses by regulating Zap70 ubiquitination. J Exp Med. 2016;213:399-414 pubmed publisher
  93. Hwang S, Jang S, Kim M, Kim L, Kim B, Kim H, et al. YY1 inhibits differentiation and function of regulatory T cells by blocking Foxp3 expression and activity. Nat Commun. 2016;7:10789 pubmed publisher
  94. Kim K, Kim N, Lee G. Transcription Factors Oct-1 and GATA-3 Cooperatively Regulate Th2 Cytokine Gene Expression via the RHS5 within the Th2 Locus Control Region. PLoS ONE. 2016;11:e0148576 pubmed publisher
  95. Ying W, Tseng A, Chang R, Wang H, Lin Y, Kanameni S, et al. miR-150 regulates obesity-associated insulin resistance by controlling B cell functions. Sci Rep. 2016;6:20176 pubmed publisher
  96. Bandyopadhyay S, Quinn T, Scandiuzzi L, Basu I, Partanen A, Tomé W, et al. Low-Intensity Focused Ultrasound Induces Reversal of Tumor-Induced T Cell Tolerance and Prevents Immune Escape. J Immunol. 2016;196:1964-76 pubmed publisher
  97. Vincendeau M, Hadian K, Messias A, Brenke J, Hålander J, Griesbach R, et al. Inhibition of Canonical NF-κB Signaling by a Small Molecule Targeting NEMO-Ubiquitin Interaction. Sci Rep. 2016;6:18934 pubmed publisher
  98. Vivar O, Masi G, Carpier J, Magalhaes J, Galgano D, Pazour G, et al. IFT20 controls LAT recruitment to the immune synapse and T-cell activation in vivo. Proc Natl Acad Sci U S A. 2016;113:386-91 pubmed publisher
  99. Jabara H, Boyden S, Chou J, Ramesh N, Massaad M, Benson H, et al. A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency. Nat Genet. 2016;48:74-8 pubmed publisher
  100. Wei R, Hu Y, Dong F, Xu X, Hu A, Gao G. Hepatoma cell-derived leptin downregulates the immunosuppressive function of regulatory T-cells to enhance the anti-tumor activity of CD8+ T-cells. Immunol Cell Biol. 2016;94:388-99 pubmed publisher
  101. Verma S, Weiskopf D, Gupta A, McDonald B, Peters B, Sette A, et al. Cytomegalovirus-Specific CD4 T Cells Are Cytolytic and Mediate Vaccine Protection. J Virol. 2016;90:650-8 pubmed publisher
  102. Alam M, Gaida M, Bergmann F, Lasitschka F, Giese T, Giese N, et al. Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression. Nat Med. 2015;21:1337-43 pubmed publisher
  103. Chen X, Serrano D, Mayhue M, Hoebe K, Ilangumaran S, Ramanathan S. GIMAP5 Deficiency Is Associated with Increased AKT Activity in T Lymphocytes. PLoS ONE. 2015;10:e0139019 pubmed publisher
  104. Nakatsukasa H, Zhang D, Maruyama T, Chen H, Cui K, Ishikawa M, et al. The DNA-binding inhibitor Id3 regulates IL-9 production in CD4(+) T cells. Nat Immunol. 2015;16:1077-84 pubmed publisher
  105. Pearce V, Bouabe H, MacQueen A, Carbonaro V, Okkenhaug K. PI3Kδ Regulates the Magnitude of CD8+ T Cell Responses after Challenge with Listeria monocytogenes. J Immunol. 2015;195:3206-17 pubmed publisher
  106. Silva O, Crocetti J, Humphries L, Burkhardt J, Miceli M. Discs Large Homolog 1 Splice Variants Regulate p38-Dependent and -Independent Effector Functions in CD8+ T Cells. PLoS ONE. 2015;10:e0133353 pubmed publisher
  107. Kamachi F, Isshiki T, Harada N, Akiba H, Miyake S. ICOS promotes group 2 innate lymphoid cell activation in lungs. Biochem Biophys Res Commun. 2015;463:739-45 pubmed publisher
  108. McCully M, Collins P, Hughes T, Thomas C, Billen J, O Donnell V, et al. Skin Metabolites Define a New Paradigm in the Localization of Skin Tropic Memory T Cells. J Immunol. 2015;195:96-104 pubmed publisher
  109. Sharma S, Chintala N, Vadrevu S, Patel J, Karbowniczek M, Markiewski M. Pulmonary alveolar macrophages contribute to the premetastatic niche by suppressing antitumor T cell responses in the lungs. J Immunol. 2015;194:5529-38 pubmed publisher
  110. Richardson E, Shukla S, Sweet D, Wearsch P, Tsichlis P, Boom W, et al. Toll-like receptor 2-dependent extracellular signal-regulated kinase signaling in Mycobacterium tuberculosis-infected macrophages drives anti-inflammatory responses and inhibits Th1 polarization of responding T cells. Infect Immun. 2015;83:2242-54 pubmed publisher
  111. Rao E, Zhang Y, Zhu G, Hao J, Persson X, Egilmez N, et al. Deficiency of AMPK in CD8+ T cells suppresses their anti-tumor function by inducing protein phosphatase-mediated cell death. Oncotarget. 2015;6:7944-58 pubmed
  112. Fischer N, Elson G, Magistrelli G, Dheilly E, Fouque N, Laurendon A, et al. Exploiting light chains for the scalable generation and platform purification of native human bispecific IgG. Nat Commun. 2015;6:6113 pubmed publisher
  113. Buchwald Z, Yang C, Nellore S, Shashkova E, Davis J, Cline A, et al. A Bone Anabolic Effect of RANKL in a Murine Model of Osteoporosis Mediated Through FoxP3+ CD8 T Cells. J Bone Miner Res. 2015;30:1508-22 pubmed publisher
  114. Tan J, Chan S, Lo C, Deane J, McDonald C, Bernard C, et al. Amnion cell-mediated immune modulation following bleomycin challenge: controlling the regulatory T cell response. Stem Cell Res Ther. 2015;6:8 pubmed publisher
  115. Hill E, Ng T, Burton B, Oakley C, Malik K, Wraith D. Glycogen synthase kinase-3 controls IL-10 expression in CD4(+) effector T-cell subsets through epigenetic modification of the IL-10 promoter. Eur J Immunol. 2015;45:1103-15 pubmed publisher
  116. Gu A, Zhang S, Wang Y, Xiong H, Curtis T, Wan Y. A critical role for transcription factor Smad4 in T cell function that is independent of transforming growth factor β receptor signaling. Immunity. 2015;42:68-79 pubmed publisher
  117. Shindo Y, Unsinger J, Burnham C, Green J, Hotchkiss R. Interleukin-7 and anti-programmed cell death 1 antibody have differing effects to reverse sepsis-induced immunosuppression. Shock. 2015;43:334-43 pubmed publisher
  118. Sakaguchi S, Hombauer M, Hassan H, Tanaka H, Yasmin N, Naoe Y, et al. A novel Cd8-cis-regulatory element preferentially directs expression in CD44hiCD62L+ CD8+ T cells and in CD8αα+ dendritic cells. J Leukoc Biol. 2015;97:635-44 pubmed publisher
  119. Rutz S, Kayagaki N, Phung Q, Eidenschenk C, Noubade R, Wang X, et al. Deubiquitinase DUBA is a post-translational brake on interleukin-17 production in T cells. Nature. 2015;518:417-21 pubmed publisher
  120. Reynolds A, Kuraoka M, Kelsoe G. Natural IgM is produced by CD5- plasma cells that occupy a distinct survival niche in bone marrow. J Immunol. 2015;194:231-42 pubmed publisher
  121. Lou Q, Zhang W, Liu G, Ma Y. The C-type lectin OCILRP2 costimulates EL4 T cell activation via the DAP12-Raf-MAP kinase pathway. PLoS ONE. 2014;9:e113218 pubmed publisher
  122. Arndt B, Witkowski L, Ellwart J, Seissler J. CD8+ CD122+ PD-1- effector cells promote the development of diabetes in NOD mice. J Leukoc Biol. 2015;97:111-20 pubmed publisher
  123. Jurkin J, Henkel T, Nielsen A, Minnich M, Popow J, Kaufmann T, et al. The mammalian tRNA ligase complex mediates splicing of XBP1 mRNA and controls antibody secretion in plasma cells. EMBO J. 2014;33:2922-36 pubmed publisher
  124. Backer R, Helbig C, Gentek R, Kent A, Laidlaw B, Dominguez C, et al. A central role for Notch in effector CD8(+) T cell differentiation. Nat Immunol. 2014;15:1143-51 pubmed publisher
  125. Fos C, Bécart S, Canonigo Balancio A, Boehning D, Altman A. Association of the EF-hand and PH domains of the guanine nucleotide exchange factor SLAT with IP₃ receptor 1 promotes Ca²⁺ signaling in T cells. Sci Signal. 2014;7:ra93 pubmed publisher
  126. Naik E, Webster J, DeVoss J, Liu J, Suriben R, Dixit V. Regulation of proximal T cell receptor signaling and tolerance induction by deubiquitinase Usp9X. J Exp Med. 2014;211:1947-55 pubmed publisher
  127. Bennaceur K, Atwill M, Al Zhrany N, Hoffmann J, Keavney B, BREAULT D, et al. Atorvastatin induces T cell proliferation by a telomerase reverse transcriptase (TERT) mediated mechanism. Atherosclerosis. 2014;236:312-20 pubmed publisher
  128. Wu C, He S, Peng Y, Kushwaha K, Lin J, Dong J, et al. TSLPR deficiency attenuates atherosclerotic lesion development associated with the inhibition of TH17 cells and the promotion of regulator T cells in ApoE-deficient mice. J Mol Cell Cardiol. 2014;76:33-45 pubmed publisher
  129. Lin C, Lo S, Hsu C, Hsieh C, Chang Y, Hou B, et al. T-cell autophagy deficiency increases mortality and suppresses immune responses after sepsis. PLoS ONE. 2014;9:e102066 pubmed publisher
  130. Boyoglu Barnum S, Chirkova T, Todd S, Barnum T, Gaston K, Jorquera P, et al. Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice. J Virol. 2014;88:10569-83 pubmed publisher
  131. Gerlach K, Hwang Y, Nikolaev A, Atreya R, Dornhoff H, Steiner S, et al. TH9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells. Nat Immunol. 2014;15:676-86 pubmed publisher
  132. Bedke T, Iannitti R, De Luca A, Giovannini G, Fallarino F, Berges C, et al. Distinct and complementary roles for Aspergillus fumigatus-specific Tr1 and Foxp3+ regulatory T cells in humans and mice. Immunol Cell Biol. 2014;92:659-70 pubmed publisher
  133. Assi H, Espinosa J, Suprise S, SOFRONIEW M, Doherty R, Zamler D, et al. Assessing the role of STAT3 in DC differentiation and autologous DC immunotherapy in mouse models of GBM. PLoS ONE. 2014;9:e96318 pubmed publisher
  134. Qian L, Zhang M, Wu S, Zhong Y, Van Tol E, Cai W. Alkylglycerols modulate the proliferation and differentiation of non-specific agonist and specific antigen-stimulated splenic lymphocytes. PLoS ONE. 2014;9:e96207 pubmed publisher
  135. Ntranos A, Hall O, Robinson D, Grishkan I, Schott J, Tosi D, et al. FTY720 impairs CD8 T-cell function independently of the sphingosine-1-phosphate pathway. J Neuroimmunol. 2014;270:13-21 pubmed publisher
  136. Koga T, Hedrich C, Mizui M, Yoshida N, Otomo K, Lieberman L, et al. CaMK4-dependent activation of AKT/mTOR and CREM-? underlies autoimmunity-associated Th17 imbalance. J Clin Invest. 2014;124:2234-45 pubmed publisher
  137. Martins K, Steffens J, Van Tongeren S, Wells J, Bergeron A, Dickson S, et al. Toll-like receptor agonist augments virus-like particle-mediated protection from Ebola virus with transient immune activation. PLoS ONE. 2014;9:e89735 pubmed publisher
  138. Bashour K, Gondarenko A, Chen H, Shen K, Liu X, Huse M, et al. CD28 and CD3 have complementary roles in T-cell traction forces. Proc Natl Acad Sci U S A. 2014;111:2241-6 pubmed publisher
  139. Yang C, Li J, Chiu L, Lan J, Chen D, Chuang H, et al. Dual-specificity phosphatase 14 (DUSP14/MKP6) negatively regulates TCR signaling by inhibiting TAB1 activation. J Immunol. 2014;192:1547-57 pubmed publisher
  140. Hu Y, Xiao H, Shi T, Oppenheim J, Chen X. Progranulin promotes tumour necrosis factor-induced proliferation of suppressive mouse CD4? Foxp3? regulatory T cells. Immunology. 2014;142:193-201 pubmed publisher
  141. Lee P, Puppi M, Schluns K, Yu Lee L, Dong C, Lacorazza H. The transcription factor E74-like factor 4 suppresses differentiation of proliferating CD4+ T cells to the Th17 lineage. J Immunol. 2014;192:178-88 pubmed publisher
  142. Iwata A, Kawashima S, Kobayashi M, Okubo A, Kawashima H, Suto A, et al. Th2-type inflammation instructs inflammatory dendritic cells to induce airway hyperreactivity. Int Immunol. 2014;26:103-14 pubmed publisher
  143. Salinas N, Olguín J, Castellanos C, Saavedra R. T cell suppression in vitro during Toxoplasma gondii infection is the result of IL-2 competition between Tregs and T cells leading to death of proliferating T cells. Scand J Immunol. 2014;79:1-11 pubmed publisher
  144. Sumitomo S, Fujio K, Okamura T, Morita K, Ishigaki K, Suzukawa K, et al. Transcription factor early growth response 3 is associated with the TGF-?1 expression and the regulatory activity of CD4-positive T cells in vivo. J Immunol. 2013;191:2351-9 pubmed publisher
  145. Roy S, Stevens M, So L, Edinger A. Reciprocal effects of rab7 deletion in activated and neglected T cells. Autophagy. 2013;9:1009-23 pubmed publisher
  146. Dufner A, Schamel W. B cell antigen receptor-induced activation of an IRAK4-dependent signaling pathway revealed by a MALT1-IRAK4 double knockout mouse model. Cell Commun Signal. 2011;9:6 pubmed publisher
  147. Sheng H, Wang Y, Jin Y, Zhang Q, Zhang Y, Wang L, et al. A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1. Cell Res. 2008;18:846-57 pubmed publisher
  148. Nakae S, Iwakura Y, Suto H, Galli S. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J Leukoc Biol. 2007;81:1258-68 pubmed
  149. Krieg C, Han P, Stone R, Goularte O, Kaye J. Functional analysis of B and T lymphocyte attenuator engagement on CD4+ and CD8+ T cells. J Immunol. 2005;175:6420-7 pubmed